News
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Who can get a COVID vaccine? The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65.
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
Italian tyre maker Pirelli is in a risky situation after its Chinese leading shareholder Sinochem rejected a proposal by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results